Intracerebral haemorrhage, what's new?;Accident vasculaire cérébral hémorragique : nouveautés sur la prise en charge

Annales Francaises d'Anesthesie et de Reanimation

Volumn 25, Issue 8, 2006, Pages 868-873

  Grillo, P ^a   Velly, L ^a   Bruder, N ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Factor VII; Haemorrhagic stroke; Surgery

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLINICAL TRIAL; DISABILITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFECT; HUMAN; INTRACRANIAL PRESSURE MONITORING; MORTALITY; ONSET AGE; STROKE;

ANIMALS; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; FACTOR VII; HEMOSTASIS; HUMANS; HYPERTENSION; RECOMBINANT PROTEINS;

EID: 33747890968     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2006.03.030     Document Type: Article

References (42)

1. Feigin V.L., Lawes C.M., Bennett D.A., and Anderson C.S. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2 (2003) 43-53
2. Sudlow C.L., and Warlow C.P. Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. Stroke 28 (1997) 491-499
3. Qureshi A.I., Tuhrim S., Broderick J.P., Batjer H.H., Hondo H., and Hanley D.F. Spontaneous intracerebral hemorrhage. N. Engl. J. Med. 344 (2001) 1450-1460
4. Qureshi A.I., Giles W.H., and Croft J.B. Racial differences in the incidence of intracerebral hemorrhage: effects of blood pressure and education. Neurology 52 (1999) 1617-1621
5. O'Donnell H.C., Rosand J., Knudsen K.A., Furie K.L., Segal A.Z., Chiu R.I., et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N. Engl. J. Med. 342 (2000) 240-245
6. Ronning O.M., Guldvog B., and Stavem K. The benefit of an acute stroke unit in patients with intracranial haemorrhage: a controlled trial. J. Neurol. Neurosurg. Psychiatry 70 (2001) 631-634
7. Fogelholm R., Murros K., Rissanen A., and Avikainen S. Long-term survival after primary intracerebral haemorrhage: a retrospective population-based study. J. Neurol. Neurosurg. Psychiatry 76 (2005) 1534-1538
8. Diringer M.N., and Edwards D.F. Admission to a neurologic-neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit. Care Med. 29 (2001) 635-640
9. Fogelholm R., Eskola K., Kiminkinen T., and Kunnamo I. Anticoagulant treatment as a risk factor for primary intracerebral haemorrhage. J. Neurol. Neurosurg. Psychiatry 55 (1992) 1121-1124
10. Franke C.L., de Jonge J., van Swieten J.C., Op de Coul A.A., and van Gijn J. Intracerebral hematomas during anticoagulant treatment. Stroke 21 (1990) 726-730
11. He J., Whelton P.K., Vu B., and Klag M.J. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 280 (1998) 1930-1935
12. Hart R.G., Benavente O., and Pearce L.A. Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: a meta-analysis and hypothesis. Cerebrovasc. Dis. 9 (1999) 215-217
13. Thrift A.G., McNeil J.J., Forbes A., and Donnan G.A. Risk of primary intracerebral haemorrhage associated with aspirin and non-steroidal anti-inflammatory drugs: case-control study. BMJ 318 (1999) 759-764
14. Rosand J., Eckman M.H., Knudsen K.A., Singer D.E., and Greenberg S.M. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch. Intern. Med. 164 (2004) 880-884
15. Oden A., and Fahlen M. Oral anticoagulation and risk of death: a medical record linkage study. BMJ 325 (2002) 1073-1075
16. Chimowitz M.I., Lynn M.J., Howlett-Smith H., Stern B.J., Hertzberg V.S., Frankel M.R., et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N. Engl. J. Med. 352 (2005) 1305-1316
17. Sloan M.A., Price T.R., Petito C.K., Randall A.M., Solomon R.E., Terrin M.L., et al. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience. Neurology 45 (1995) 649-658
18. Schellinger P., Fiebach J., Mohr A., Ringleb P., Jansen O., and Hacke W. Thrombolytic therapy for ischemic stroke-A review. Part I-Intravenous thrombolysis. Crit. Care Med. 29 (2001) 1812-1818
19. Larrue V., von Kummer R.R., Muller A., and Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 32 (2001) 438-441
20. Feldmann E., Broderick J.P., Kernan W.N., Viscoli C.M., Brass L.M., Brott T., et al. Major risk factors for intracerebral hemorrhage in the young are modifiable. Stroke 36 (2005) 1881-1885
21. Brott T., Thalinger K., and Hertzberg V. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke 17 (1986) 1078-1083
22. Mayer S.A., and Rincon F. Treatment of intracerebral haemorrhage. Lancet Neurol. 4 (2005) 662-672
23. Hemphill III J.C., Bonovich D.C., Besmertis L., Manley G.T., and Johnston S.C. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 32 (2001) 891-897
24. Gebel J.M., Sila C.A., Sloan M.A., Granger C.B., Weisenberger J.P., Green C.L., et al. Comparison of the ABC/2 estimation technique to computer-assisted volumetric analysis of intraparenchymal and subdural hematomas complicating the GUSTO-1 trial. Stroke 29 (1998) 1799-1801
25. Brott T., Broderick J., Kothari R., Barsan W., Tomsick T., Sauerbeck L., et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28 (1997) 1-5
26. Kazui S., Naritomi H., Yamamoto H., Sawada T., and Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 27 (1996) 1783-1787
27. Boulis N.M., Bobek M.P., Schmaier A., and Hoff J.T. Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 45 (1999) 1113-1118 (discussion 8-9)
28. Fredriksson K., Norrving B., and Stromblad L.G. Emergency reversal of anticoagulation after intracerebral hemorrhage. Stroke 23 (1992) 972-977
29. Phan T.G., Koh M., and Wijdicks E.F. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch. Neurol. 57 (2000) 1710-1713
30. Eckman M.H., Rosand J., Knudsen K.A., Singer D.E., and Greenberg S.M. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 34 (2003) 1710-1716
31. Mayer S.A., Brun N.C., Begtrup K., Broderick J., Davis S., Diringer M.N., et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N. Engl. J. Med. 352 (2005) 777-785
32. Fogelholm R., Avikainen S., and Murros K. Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke 28 (1997) 1396-1400
33. Ohwaki K., Yano E., Nagashima H., Hirata M., Nakagomi T., and Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 35 (2004) 1364-1367
34. Qureshi A.I., Wilson D.A., Hanley D.F., and Traystman R.J. No evidence for an ischemic penumbra in massive experimental intracerebral hemorrhage. Neurology 52 (1999) 266-272
35. Schellinger P.D., Fiebach J.B., Hoffmann K., Becker K., Orakcioglu B., Kollmar R., et al. Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra?. Stroke 34 (2003) 1674-1679
36. Powers W.J., Zazulia A.R., Videen T.O., Adams R.E., Yundt K.D., Aiyagari V., et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology 57 (2001) 18-24
37. Qureshi A.I., Mohammad Y.M., Yahia A.M., Suarez J.I., Siddiqui A.M., Kirmani J.F., et al. A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J. Intensive Care Med. 20 (2005) 34-42
38. Marti-Fabregas J., Belvis R., Guardia E., Cocho D., Munoz J., Marruecos L., et al. Prognostic value of Pulsatility Index in acute intracerebral hemorrhage. Neurology 61 (2003) 1051-1056
39. Cruz J., Minoja G., and Okuchi K. Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: a randomized trial. Neurosurgery 51 (2002) 628-637
40. Mendelow A.D., Gregson B.A., Fernandes H.M., Murray G.D., Teasdale G.M., Hope D.T., et al. Early surgery vs initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 365 (2005) 387-397
41. St Louis E.K., Wijdicks E.F., and Li H. Predicting neurologic deterioration in patients with cerebellar hematomas. Neurology 51 (1998) 1364-1369
42. Teernstra O.P., Evers S.M., Lodder J., Leffers P., Franke C.L., and Blaauw G. Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke 34 (2003) 968-974